Cat.#: ACPP-1345
| Despition | DISC1 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1463 | Human BCL2L11 Protein (AC1463) | 2 µg | inquiry |
| ACPP-1170 | GAPDH Blocking Peptide (AC1170) | 250 µg | inquiry |
| ACPP-1310 | SHC Blocking Peptide (AC1310) | 250 µg | inquiry |
| ACPP-1705 | Human NXPH1 Protein (AC1705) | 5 µg | inquiry |
| ACPP-1243 | ELOVL4 Blocking Peptide (AC1243) | 250 µg | inquiry |
| ACPP-1504 | Human CPLX1 Protein (AC1504) | 10 µg | inquiry |
| ACPP-1613 | Human RAB3IL1 Protein (AC1613) | 2 µg | inquiry |
| ACPP-1716 | Mouse ANGPTL7 Protein (AC1716) | 1 µg | inquiry |
| ACPP-1307 | NPY2R Blocking Peptide (AC1307) | 250 µg | inquiry |
| ACPP-1205 | Human MECP2 Protein (AC1205) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.